Trygg Pharma acquires Epax from Austevoll Seafood

Trygg Pharma AS - a company that will be jointly owned by Aker BioMarine ASA and

an affiliate of Lindsay Goldberg LLC through a newly established joint venture

company (cf. the separate notice of today) - has entered into an agreement to

acquire 100% of the shares in Epax Holding AS (together with its subsidiaries

"Epax"), a wholly owned subsidiary of Austevoll Seafood ASA. Epax is the world's

premier high concentrate omega-3 supplement manufacturer. Epax employs a total

of 74 people.

Please see attached.

For further information regarding Trygg Pharma and Epax, please contact:

Egil Bodd, Chairman of the board, Trygg Pharma, tel.: +47 900 20 341

Aaron Kramer, CEO, Trygg Pharma, tel.: +47 916 30 130

For further information regarding Aker BioMarine, please contact:

Fredrik Nygaard, CFO and IR contact, Aker BioMarine, tel.: +47 24 13 00 00

This information is subject of the disclosure requirements acc. to §5-12 vphl

(Norwegian Securities Trading Act)

[HUG#1442506]

AI assistant